Robert W. Baird raised its price target on Amgen (Nasdaq: AMGN) to $65, reiterating their Outperform rating, saying yesterday's news ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE